Legal Representation
Attorney
Jelena Libby
USPTO Deadlines
Next Deadline
8 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
August 06, 2025
Extension Available
Until August 06, 2025
Application History
19 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 1, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 1, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Feb 1, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jan 31, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 6, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 11, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 11, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 22, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 9, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 8, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 8, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 8, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 8, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 8, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 8, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 7, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 21, 2023 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Jun 20, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 22, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 041
Education services, namely, providing courses, presentations, and training for patients and medical professionals, in the field of oncology, autoimmune, and inflammatory diseases and disorders; Providing online non-downloadable electronic publications in the nature of brochures in the field of oncology, autoimmune and inflammatory diseases and disorders
Class 044
Providing medical information in the field of oncology, autoimmune, and inflammatory diseases and disorders
Additional Information
Design Mark
The mark consists of the word "TECENTRIQ" written in a stylized font with the word "HYBREZA" written in a stylized font under it. The first "T" in the word "TECENTRIQ" has three arrows pointing inwards in a circle above it in the upper left hand corner.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
041
044